Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Rectal Infiltration of Exparel vs. 0.25% Bupivacaine With Epinephrine vs. Placebo for Analgesic Benefit Following Hemorrhoidectomy

NCT02104414 is registered in ClinicalTrials.gov with St. Luke's-Roosevelt Hospital Center as lead sponsor.

NCT NCT02104414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02104414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Rectal Infiltration of Exparel vs. 0.25% Bupivacaine With Epinephrine vs. Placebo for Analgesic Benefit Following Hemorrhoidectomy
Lead sponsor
St. Luke's-Roosevelt Hospital Center
Phase
Phase 4
Overall status
Terminated
Start date
April 30, 2014
Completion date
January 31, 2016
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhoid